FDA Webview Site FDA Review Site FDA Updater Site
header.gif
Username:
Password:
 

human drugs
animal drugs
biologics
eirs 483s
medical devices
marketing
email
search our site
  
FDA-RELATED NEWS
 
 
 
TXT 62% of Americans Fear Vaccine Political Pressure: Poll
09/10/2020
 
 
TXT 8 FDA Execs Say Agency is ‘Following the Science’
09/10/2020
 
 
TXT Covid-19 Vaccine ‘Emergency Use’ Guide Soon: FDA
09/11/2020
 
 
TXT Return Drug Manufacturing to U.S.: Hahn, Shah
09/10/2020
 
 
TXT Covid Vaccine Hold Should not Slow Development: Fauci
09/09/2020
 
 
TXT Vaccine Companies Pledge Scientific, Ethical Rigor
09/08/2020
 
 
TXT Researchers Caution Hospitals on Drug Industry Money
09/09/2020
 
 
TXT CBER Untitled Letter Over Unapproved Cellular Product
09/11/2020
 
 
TXT Industry Defense Shows FDA is ‘Politically Impaired’: Column
09/10/2020
 
 
TXT FDA Promoting Covid Test Development: Shuren
09/09/2020
 
 
TXT Court Rejects Some Boehringer Ad Claims
09/09/2020
 
 
TXT Alert on Hot/Cold Therapy Devices
09/09/2020
 
 
TXT Guidance on Impaired Renal Function Pharmacokinetics
09/08/2020
 
 
TXT Suggestions on DTC Research
09/08/2020
 
 
TXT Since Our Last Issue ...
09/13/2020
 
 
TXT Product Approval Summaries
09/13/2020
 
 
TXT Latest Federal Register Notices
09/13/2020
 
 
TXT Pharmacy Plus Warning on Unapproved Covid Products
09/11/2020
 
 
TXT RLC Labs Recalls Subpotent Thyroid Products
09/11/2020
 
 
TXT FDA Holds Up Sarepta Gene Therapy Trial
09/10/2020
 
 
TXT FDA Warns 17 Web Sites Illegally Selling Opioids
09/10/2020
 
 
TXT FDA Updates Covid MDR Questions, Answers
09/09/2020
 
 
TXT Consistent Hedgehog Inhibitor Labeling Sought
09/08/2020
 
 
TXT FDA Wants Feedback on Device Premarket Tracker
09/08/2020
 
 
TXT Latest FDA Warning Letters
09/08/2020
 
 
TXT Breast Cancer Drug Combination Doesn’t Work: FDA
09/08/2020
 
 
TXT CGMP Violations at PT MegaSurya Mas
09/08/2020
 
 
TXT Calvin Scott & Company CGMP Violations
09/08/2020
 
 
 
 
The most authoritative FDA news analysis each week is found in the pages of Dickinson's FDA Review. Since 1984, this newsletter has been providing in-depth reports on the most significant FDA developments affecting the pharmaceutical, medical device, biologics and veterinary medicines industries. Unlike other media, FDA Review eliminates time-wasting minutia and presents in clear, concise language the essence of what's really important - and why. It is the publication that FDA officials themselves read. Delivered in the middle of each week, FDA Review presents:
  • The latest agency policy developments, often before they're officially announced;
  • Major news insights, follow-ups and reactions in each product area;
  • Summaries of the latest Warning Letters;
  • The newest product approvals;
  • Summaries of the latest FDA Federal Register notices;
  • Summaries of DDMAC letters;
  • Related industry news capsules;
  • The industry's most concise FDA news index;
  • Inside-FDA news briefs
You can rely on FDA Review to provide only what's important - in the most convenient and time-saving